These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10439528)

  • 1. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.
    Phan TG; Wong RC; Crotty K; Adelstein S
    Australas J Dermatol; 1999 Aug; 40(3):153-7. PubMed ID: 10439528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxis.
    Bannaga A; Rahama O; Barlow G
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23625676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Fagot JP; Mockenhaupt M; Bouwes-Bavinck JN; Naldi L; Viboud C; Roujeau JC;
    AIDS; 2001 Sep; 15(14):1843-8. PubMed ID: 11579247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports.
    Dodi F; Alessandrini A; Camera M; Gaffuri L; Morandi N; Pagano G
    AIDS; 2002 May; 16(8):1197-8. PubMed ID: 12004287
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins.
    Tan A; Tan HH; Lee CC; Ng SK
    Clin Exp Dermatol; 2003 May; 28(3):269-71. PubMed ID: 12780710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe eye complications from toxic epidermal necrolysis following initiation of Nevirapine based HAART regimen in a child with HIV infection: a case from Cameroon.
    Tchetnya X; Ngwasiri CA; Munge T; Aminde LN
    BMC Pediatr; 2018 Mar; 18(1):108. PubMed ID: 29534693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.
    Rotunda A; Hirsch RJ; Scheinfeld N; Weinberg JM
    Acta Derm Venereol; 2003; 83(1):1-9. PubMed ID: 12636014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stevens-Johnson syndrome due to nevirapine].
    García Fernández D; García-Patos Briones V; Mollet Sánchez J; Castells Rodellas A
    Rev Clin Esp; 2000 Mar; 200(3):179-80. PubMed ID: 10804771
    [No Abstract]   [Full Text] [Related]  

  • 12. Nevirapine-induced overlap stevens-johnson syndrome/toxic epidermal necrolysis.
    Wetterwald E; Le Cleach L; Michel C; David F; Revuz J
    Br J Dermatol; 1999 May; 140(5):980-2. PubMed ID: 10354056
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus.
    Pahk R; Azu MC; Taira BR; Sandoval S
    Clin Exp Dermatol; 2009 Dec; 34(8):e775-7. PubMed ID: 19778313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nevirapine-associated Stevens-Johnson syndrome.
    Warren KJ; Boxwell DE; Kim NY; Drolet BA
    Lancet; 1998 Feb; 351(9102):567. PubMed ID: 9492778
    [No Abstract]   [Full Text] [Related]  

  • 15. Nevirapine-induced Stevens-Johnson syndrome in a mother and son.
    Liechty CA; Solberg P; Mwima G; Were W; Weidle PJ; Mermin J
    AIDS; 2005 Jun; 19(9):993-4. PubMed ID: 15905686
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection.
    Pollard RB; Robinson P; Dransfield K
    Clin Ther; 1998; 20(6):1071-92. PubMed ID: 9916603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-nucleoside reverse transcriptase inhibitor as a fully viable alternative. Strong therapy start without protease inhibitor].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():30-3. PubMed ID: 10863307
    [No Abstract]   [Full Text] [Related]  

  • 18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic epidermal necrolysis in relation with nevirapine].
    Vera Méndez FJ; Martínez Madrid OJ; García Henarejos JA; García Solano J; Vilaplana García R
    An Med Interna; 2000 Aug; 17(8):448-9. PubMed ID: 11218998
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.